DK131891C - Fremgangsmade til fremstilling af et pulverpreparat til inhalation - Google Patents

Fremgangsmade til fremstilling af et pulverpreparat til inhalation

Info

Publication number
DK131891C
DK131891C DK392872A DK392872A DK131891C DK 131891 C DK131891 C DK 131891C DK 392872 A DK392872 A DK 392872A DK 392872 A DK392872 A DK 392872A DK 131891 C DK131891 C DK 131891C
Authority
DK
Denmark
Prior art keywords
inhalation
preparing
procedure
powder preparation
powder
Prior art date
Application number
DK392872A
Other languages
Danish (da)
English (en)
Other versions
DK131891B (da
Inventor
D R Macarthur
D E Smith
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK131891(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to GB3745671A priority Critical patent/GB1410588A/en
Priority to ZM119/71*UA priority patent/ZM11971A1/xx
Priority to IL39990A priority patent/IL39990A/en
Priority to CA148,628A priority patent/CA992461A/en
Priority to NL7210780A priority patent/NL7210780A/xx
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to DE2239091A priority patent/DE2239091A1/de
Priority to DK392872A priority patent/DK131891C/da
Priority to SE7210331A priority patent/SE411842B/sv
Priority to FR7228877A priority patent/FR2150759B1/fr
Priority to JP7955772A priority patent/JPS5652001B2/ja
Priority to IE48/73A priority patent/IE37102B1/xx
Priority to ZA730284A priority patent/ZA73284B/xx
Priority to AU51191/73A priority patent/AU5119173A/en
Priority to AT39073*#A priority patent/AT333974B/de
Priority to LU66875A priority patent/LU66875A1/xx
Priority to NO268/73A priority patent/NO140747C/no
Priority to FI191/73A priority patent/FI56487C/fi
Priority to ES410910A priority patent/ES410910A1/es
Priority to DK535774A priority patent/DK146974C/da
Priority to US05/584,888 priority patent/US4009280A/en
Publication of DK131891B publication Critical patent/DK131891B/da
Publication of DK131891C publication Critical patent/DK131891C/da
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK392872A 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation DK131891C (da)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
ZM119/71*UA ZM11971A1 (en) 1971-08-10 1971-08-26 Chemical compounds
IL39990A IL39990A (en) 1971-08-10 1972-07-25 Pharmaceutical preparation containing 1,3-bis dinatran salt (2-carboxychromone-5-ileoxy) -Propane-2-ol
CA148,628A CA992461A (en) 1971-08-10 1972-08-03 Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol
NL7210780A NL7210780A (OSRAM) 1971-08-10 1972-08-07
DE2239091A DE2239091A1 (de) 1971-08-10 1972-08-09 Pharmazeutische pulverzusammensetzung
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
SE7210331A SE411842B (sv) 1971-08-10 1972-08-09 Forfarande for framstellning av ett pulverformigt lekemedelspreparat for inhalering
FR7228877A FR2150759B1 (OSRAM) 1971-08-10 1972-08-10
JP7955772A JPS5652001B2 (OSRAM) 1971-08-10 1972-08-10
IE48/73A IE37102B1 (en) 1971-08-10 1973-01-12 Composition
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
AT39073*#A AT333974B (de) 1971-08-10 1973-01-18 Verfahren zur herstellung eines pulverformigen inhalationspraparates
LU66875A LU66875A1 (OSRAM) 1971-08-10 1973-01-22
NO268/73A NO140747C (no) 1971-08-10 1973-01-23 Fremgangsmaate til fremstilling av et lett fluidiserbart pulverformig inhaleringspreparat
FI191/73A FI56487C (fi) 1971-08-10 1973-01-24 Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol
US05/584,888 US4009280A (en) 1971-08-10 1975-06-09 Powder composition for inhalation therapy

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (2)

Publication Number Publication Date
DK131891B DK131891B (da) 1975-09-22
DK131891C true DK131891C (da) 1976-02-23

Family

ID=36763080

Family Applications (2)

Application Number Title Priority Date Filing Date
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Country Status (19)

Country Link
US (1) US4009280A (OSRAM)
JP (1) JPS5652001B2 (OSRAM)
AT (1) AT333974B (OSRAM)
AU (1) AU5119173A (OSRAM)
CA (1) CA992461A (OSRAM)
DE (1) DE2239091A1 (OSRAM)
DK (2) DK131891C (OSRAM)
ES (1) ES410910A1 (OSRAM)
FI (1) FI56487C (OSRAM)
FR (1) FR2150759B1 (OSRAM)
GB (1) GB1410588A (OSRAM)
IE (1) IE37102B1 (OSRAM)
IL (1) IL39990A (OSRAM)
LU (1) LU66875A1 (OSRAM)
NL (1) NL7210780A (OSRAM)
NO (1) NO140747C (OSRAM)
SE (1) SE411842B (OSRAM)
ZA (1) ZA73284B (OSRAM)
ZM (1) ZM11971A1 (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042819A (OSRAM) * 1973-08-20 1975-04-18
JPS5042827A (OSRAM) * 1973-08-20 1975-04-18
JPS5042826A (OSRAM) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (OSRAM) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
JP4526702B2 (ja) † 1997-09-29 2010-08-18 ネクター セラピューティックス 安定化生物活性処方物およびその使用方法
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
EP1345629A2 (en) * 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
EP1455755B1 (en) * 2001-11-20 2013-04-17 Civitas Therapeutics, Inc. Improved particulate compositions for pulmonary delivery
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2364636T3 (es) * 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
KR101657029B1 (ko) * 2008-07-24 2016-09-12 레르 리키드 쏘시에떼 아노님 뿌르 레드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZA73284B (en) 1973-11-28
NL7210780A (OSRAM) 1973-02-13
ES410910A1 (es) 1976-07-16
GB1410588A (en) 1975-10-22
FR2150759B1 (OSRAM) 1975-10-31
NO140747B (no) 1979-07-30
DK535774A (OSRAM) 1975-06-02
DK146974B (da) 1984-03-05
AU5119173A (en) 1974-07-18
FR2150759A1 (OSRAM) 1973-04-13
JPS5652001B2 (OSRAM) 1981-12-09
SE411842B (sv) 1980-02-11
ATA39073A (de) 1976-04-15
IE37102B1 (en) 1977-05-11
IL39990A0 (en) 1972-09-28
LU66875A1 (OSRAM) 1973-03-23
DK146974C (da) 1984-08-13
DE2239091A1 (de) 1973-02-22
DK131891B (da) 1975-09-22
CA992461A (en) 1976-07-06
IL39990A (en) 1977-02-28
NO140747C (no) 1979-11-07
AT333974B (de) 1976-12-27
FI56487C (fi) 1980-02-11
JPS4826764A (OSRAM) 1973-04-09
FI56487B (fi) 1979-10-31
US4009280A (en) 1977-02-22
ZM11971A1 (en) 1973-02-21

Similar Documents

Publication Publication Date Title
DK131891C (da) Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK513578A (da) Fremgangsmaade til fremstilling af triazolylbenzopenoner
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
SE348961C (sv) Forfarande for framstellning av en sintrad pulverkropp
DK158614C (da) Fremgangsmaade til fremstilling af et dihalogenvinylcyclopropancarboxylat
NO142735C (no) Fremgangsmaate for fremstilling av et veterinaerpreparat
DK141586C (da) Fremgangsmaade til fremstilling af et humleoliepraeparat
SE384798B (sv) Forfarande for framstellning av ett laktulospulver
NO146044C (no) Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk
SE417207B (sv) Foerfarande foer framstaellning av en 3-metylencefalosporinfoerening
DK157032C (da) Fremgangsmaade til fremstilling af en vandig bitumenholdig emulsion
SE435619B (sv) Forfarande for framstellning av en 6alfa-deoxitetracyklin
DK143654C (da) Fremgangsmaade til fremstilling af et fluoranderivat af triphenylmethan
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
DK131890C (da) Fremgangsmade til fremstilling af en tandplejemiddelgel
DK132002C (da) Fremgangsmade til fremstilling af granuler med pesticid virkning
DK139521C (da) Fremgangsmaade til fremstilling af ren krystallinsk penicillinacylase
DK144312C (da) Fremgangsmaade til fremstilling af et lactulosepulver til terapeutisk anvendelse
DK137118B (da) Fremgangsmade til fremstilling af et lh-rh-preparat til nasal applikation
DK145462C (da) Fremgangsmaade til fremstilling af 15-alkyl-prostaglandin e-forbindelser
SE408898B (sv) Foerfarande foer framstaelling av en 17-monoester av 17alfa, 21-dihydroxisteroider
DK147343C (da) Fremgangsmaade til fremstilling af en fritstroemmende partikelformet phosphatesterkomposition
SE380711B (sv) Forfarande for framstellning av en pulverformig, fririnnande, vispbar komposition
DK133496C (da) Fremgangsmade til fremstilling af en streptokinaseholdig fibrinolyseaktivator